80 completed, 19 unknown, 16 recruiting, 9 active not recruiting. 139 Phase 2, 23 Phase 1, 9 Phase 3.
Follow Mild Cognitive Impairment: new trials by email Literature Review of Mild Cognitive Impairment trials Research Report on Mild Cognitive Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients 2-hydroxybenzylamine acetate, Placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 / Phase 2 | Not yet recruiting | MTI Biotech Inc | 48 | 2026-09-01 | 2026-09-24 |
| Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. human Mesenchymal Stem Cells - Mild Cognitive Impairment, Early Alzheimer's Disease | Phase 2 | Recruiting | Bernard (Barry) Baumel | 10 | 2026-05-15 | 2026-05-28 |
| Sense4Safety Intervention Sense4Safety - Mild Cognitive Impairment | Phase 1 / Phase 2 | Recruiting | University of Pennsylvania | 200 | 2026-02-19 | 2026-03-19 |
| Glymphatic Function TMS Study Transcranial Magnetic Stimulation - Mild Cognitive Impairment | Phase 2 | Not yet recruiting | University of Arizona | 20 | 2026-01-01 | 2025-12-17 |
| Epileptic Hippocampus in Alzheimer's Disease Brivaracetam - Alzheimer Disease, Mild Cognitive Impairment | Phase 1 / Phase 2 | Not yet recruiting | University of California, Los Angeles | 25 | 2026-01-01 | 2026-01-27 |
| The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment Metfomin - Mild Cognitive Impairment, Overweight or Obesity | Phase 1 / Phase 2 | Recruiting | Fudan University | 54 | 2025-09-01 | 2026-02-09 |
| Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol 18F-Florbetapir or 18F-Flutemetamol - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Recruiting | Akiva Mintz | 200 | 2025-05-20 | 2026-04-13 |
| SNIFF - 3-Week Aptar CPS Device Insulin (Humulin® R U-100), Placebo, Aptar Pharma CPS Intranasal Delivery Device - Mild Cognitive Impairment, Cognitive Impairment | Phase 2 | Withdrawn | Wake Forest University Health Sciences | 2025-05-01 | 2025-07-28 | |
| A Study of NTRX-07 in Participants With Alzheimer's Disease NTRX-07, Placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Completed | NeuroTherapia, Inc. | 48 | 2025-03-01 | 2026-10-29 |
| Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI Sublingual administration, Electroencephalography, Biochemical mesurements - Mild Cognitive Impairment, Anxiety State | Phase 1 / Phase 2 | Completed | Biomind Labs Inc. | 20 | 2024-12-15 | 2025-04-09 |
| Clinical Trial of AGB101 for Mild Cognitive Impairment AGB101, Placebo - Mild Cognitive Impairment, Prodromal Alzheimer's Disease | Phase 2 | Withdrawn | AgeneBio | 2024-12-03 | 2025-05-25 | |
| Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment IV Ketamine - Depression, Mild Cognitive Impairment | Phase 2 | Active not recruiting | Icahn School of Medicine at Mount Sinai | 15 | 2024-11-01 | 2025-01-29 |
| A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI) Lamivudine 300 MG - Mild Cognitive Impairment | Phase 2 | Active not recruiting | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 23 | 2024-10-28 | 2025-12-04 |
| The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults Mitoquinone Mesylate, Placebo capsule - Frailty, Mild Cognitive Impairment | Phase 2 | Recruiting | UConn Health | 60 | 2024-10-07 | 2026-08-12 |
| tDCS for Post-Stroke Cognitive Impairment Transcranial Dirrect Current Stimulation - Stroke, Mild Cognitive Impairment | Phase 2 | Recruiting | University of Oklahoma | 80 | 2024-09-30 | 2024-10-10 |
| Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD Ginkgo biloba extract 50 dropping pills, Ginkgo biloba extract Ginkgo biloba extract 50 Drops simulant - Mild Cognitive Impairment | Phase 2 / Phase 3 | Active not recruiting | Beijing Tiantan Hospital | 144 | 2024-09-27 | 2026-10-08 |
| RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β Resveratrol, Quercetin, and Curcumin (RQC), Curcumin - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Not yet recruiting | Zaparackas and Knepper LTD | 200 | 2024-07-01 | 2024-06-26 |
| Novel Augmentation of DAOIB and Antioxidant for Early Dementia DAOIB plus AO, DAOIB plus placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Recruiting | Chang Gung Memorial Hospital | 80 | 2024-06-19 | 2026-03-19 |
| COMMETS- Combination MCI Metabolic Syndrome Semaglutide, Intranasal insulin, Semaglutide placebo - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Recruiting | Rutgers, The State University of New Jersey | 80 | 2024-01-30 | 2026-07-27 |
| CBD for Individuals at Risk for Alzheimer's Disease Cannabidiol, Placebo - Mild Cognitive Impairment | Phase 2 | Recruiting | University of Colorado, Denver | 236 | 2024-01-19 | 2026-06-15 |
Showing 20 of 139. Sign in to see all of them.
Cognitive Dysfunction (139) · Alzheimer Disease (74) · Dementia (17) · Memory Disorders (9) · Neurodegenerative Diseases (6) · Parkinson Disease (6) · Cognition Disorders (5) · Tauopathies (5) · Brain Diseases (4) · Central Nervous System Diseases (4) · Inflammation (4) · Neurocognitive Disorders (4) · Depression (3) · Insulin Resistance (3) · Metabolic Syndrome (3)
Mental Disorders (137) · Neurocognitive Disorders (135) · Cognition Disorders (134) · Nervous System Diseases (87) · Brain Diseases (85) · Central Nervous System Diseases (85) · Neurodegenerative Diseases (73) · Tauopathies (69) · Dementia (64) · Pathological Conditions, Signs and Symptoms (22) · Signs and Symptoms (14) · Neurologic Manifestations (12) · Neurobehavioral Manifestations (11) · Nutritional and Metabolic Diseases (10) · Metabolic Diseases (9)
Insulin (6) · florbetapir (5) · Levetiracetam (3) · Quercetin (3) · Sodium Chloride (3) · Transcranial Direct Current Stimulation (3) · Atorvastatin (2) · Curcumin (2) · Dasatinib (2) · Donepezil (2) · Insulin Detemir (2) · Memantine (2) · Metformin (2) · Tablets (2) · Tobacco Use Cessation Devices (2)
Wake Forest University Health Sciences (5) · Avid Radiopharmaceuticals (4) · Chang Gung Memorial Hospital (4) · University of Washington (4) · Emory University (3) · Massachusetts General Hospital (3) · AgeneBio (2) · Beijing Tiantan Hospital (2) · Columbia University (2) · Jae Seung Kim (2) · Johns Hopkins University (2) · New York State Psychiatric Institute (2) · Sutter Health (2) · The University of Texas Health Science Center at San Antonio (2) · University of Arizona (2)
United States (84) · Netherlands (6) · Australia (5) · France (5) · Spain (5) · Taiwan (5) · Canada (4) · China (4) · Germany (4) · United Kingdom (4) · Czechia (3) · Ireland (3) · Singapore (3) · Sweden (3) · Finland (2)
Suzanne Craft, PhD (8) · Philip Scheltens, MD (2) · Adrian S Wagg, MD (1) · Agnes Floeel, Prof. (1) · Alexander C Conley, PhD (1) · Allan I. Levey, MD, PhD (1) · Andreana Haley, Ph.D. (1) · Arjan Blokland, Prof. Dr. (1) · Ashley I. Bush (1) · Barry Halliwell (1) · Barry Rovner, MD (1) · Bernard S. Baumel, MD (1) · Brian D Ross (1) · Bruno Vellas, MD (1)
PMID 34366147, PMID 20204386, PMID 20664181, PMID 21911655, PMID 22869065, PMID 23040716, PMID 23528880, PMID 23689947, PMID 24716655, PMID 25589719, PMID 26420886, PMID 26433119, PMID 26559790, PMID 26890736, PMID 26912492, PMID 26967219, PMID 27037094, PMID 27511061, PMID 27871675, PMID 28095900, PMID 28181118, PMID 28326010, PMID 28950419, PMID 29016744, PMID 29336496, PMID 29371333, PMID 29379114, PMID 29446769, PMID 29573529, PMID 31236801, PMID 31248555, PMID 31424410, PMID 31492718, PMID 31518224, PMID 31535829, PMID 31810978, PMID 31834916, PMID 32115470, PMID 32116309, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32761160, PMID 32854852, PMID 32980252, PMID 33030307, PMID 33189083, PMID 33282811
2018 (2), 2016 (1), 2017 (1), 2019 (1), IK2RX002938 (1), K01AG054731 (1), K01AG080164 (1), P30AG024978 (1), P50AG005136 (1), R01AG025502 (1), R01AG025515 (1), R01AG025525 (1), R01AG026413 (1), R01AG027415 (1), R01AG028746 (1)